Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT00885326
Title N2007-02:Bevacizumab,Cyclophosphamide,and Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors New Approaches to Neuroblastoma Therapy Consortium
Age Groups: child | adult
Covered Countries USA | CAN

No variant requirements are available.